Schering's Echovist 200 on UK market:
This article was originally published in Clinica
Executive Summary
German company Schering launched its contrast agent Echovist 200 for gynaecological applications in the UK in March, not Echovist 300 as stated in Clinica No 697, p 17. Echovist 300 was developed for cardiac applications and is not expected to be introduced in the UK at all since next-generation Levovist is close to market.